Idliopathic Pulmonary Fibrosis: Phenotypes and Comorbidities

被引:39
作者
Fell, Charlene D. [1 ,2 ]
机构
[1] Univ Calgary, Div Respirol, Calgary, AB T1Y 6J4, Canada
[2] Peter Lougheed Hosp, Calgary, AB T1Y 6J4, Canada
关键词
Idiopathic pulmonary fibrosis; Phenotypes; Comorbidities; Pulmonary hypertension; Emphysema; QUALITY-OF-LIFE; ACID GASTROESOPHAGEAL-REFLUX; LUNG-CANCER; ARTERIAL-HYPERTENSION; PREDICTIVE FACTORS; ACUTE EXACERBATION; HIGH PREVALENCE; ALVEOLITIS; EMPHYSEMA; SURVIVAL;
D O I
10.1016/j.ccm.2011.12.005
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Idiopathic pulmonary fibrosis (IPF) is a progressive fatal disease of the lung with an unknown etiology and limited treatment options. Three distinct phenotypes of IPF have been proposed: combined pulmonary fibrosis and emphysema, disproportionate pulmonary hypertension in IPF, and rapidly progressive IPF. Although treatment options for IPF are limited, much can be done to identify and alleviate symptoms from comorbidities, potentially improving the overall quality of life and well-being of these patients. This article describes emerging evidence to support the hypothesis that there is more than one phenotype for IPF and describes the common comorbidities seen in this disease.
引用
收藏
页码:51 / +
页数:8
相关论文
共 63 条
  • [1] Agarwal R, 2005, Indian J Chest Dis Allied Sci, V47, P267
  • [2] [Anonymous], 2010, GIL TERM PH IN PRESS
  • [3] Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease
    Arcasoy, SM
    Christie, JD
    Ferrari, VA
    Sutton, MS
    Zisman, DA
    Blumenthal, NP
    Pochettino, A
    Kotloff, RM
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (05) : 735 - 740
  • [4] Baddini Martinez JA, 2002, MED SCI MONITOR, V8, pR405
  • [5] Medical therapy for pulmonary arterial hypertension - Updated ACCP evidence-based clinical practice guidelines
    Badesch, David B.
    Abman, Steven H.
    Simonneau, Gerald
    Rubin, Lewis J.
    McLaughlin, Vallerie V.
    [J]. CHEST, 2007, 131 (06) : 1917 - 1928
  • [6] Diagnosis and differential assessment of pulmonary arterial hypertension
    Barst, RJ
    McGoon, M
    Torbicki, A
    Sitbon, O
    Krowka, MJ
    Olschewski, H
    Gaine, S
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) : 40S - 47S
  • [7] Cigarette smoking: A risk factor for idiopathic pulmonary fibrosis
    Baumgartner, KB
    Samet, JM
    Stidley, CA
    Colby, TV
    Waldron, JA
    Coultas, DB
    Davis, GS
    Garcia, JGN
    Hunninghake, GW
    Kallay, MC
    King, TE
    Krowka, MJ
    Rennard, SI
    Ryu, JH
    Sherman, CB
    Smith, LJ
    Toews, G
    Winterbauer, RH
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (01) : 242 - 248
  • [8] Assessment of health-related quality of life in patients with interstitial lung disease
    Chang, JA
    Curtis, JR
    Patrick, DL
    Raghu, G
    [J]. CHEST, 1999, 116 (05) : 1175 - 1182
  • [9] Acute exacerbations of idiopathic pulmonary fibrosis
    Collard, Harold R.
    Moore, Bethany B.
    Flaherty, Kevin R.
    Brown, Kevin K.
    Kaner, Robert J.
    King, Talmadge E., Jr.
    Lasky, Joseph A.
    Loyd, James E.
    Noth, Imre
    Olman, Mitchell A.
    Raghu, Ganesh
    Roman, Jesse
    Ryu, Jay H.
    Zisman, David A.
    Hunninghake, Gary W.
    Colby, Thomas V.
    Egan, Jim J.
    Hansell, David M.
    Johkoh, Takeshi
    Kaminski, Naftali
    Kim, Dong Soon
    Kondoh, Yasuhiro
    Lynch, David A.
    Mueller-Quernheim, Joachim
    Myers, Jeffrey L.
    Nicholson, Andrew G.
    Selman, Moises
    Toews, Galen B.
    Wells, Athol U.
    Martinez, Fernando J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (07) : 636 - 643
  • [10] Sildenafil improves walk distance in idiopathic pulmonary fibrosis
    Collard, Harold R.
    Anstrom, Kevin J.
    Schwarz, Marvin I.
    Zisman, David A.
    [J]. CHEST, 2007, 131 (03) : 897 - 899